Roche (Japan)
In research, Roche (Japan) stands highest in Life Sciences (#10,999 of 14,347 worldwide), over all time.
- World rank, all time
- #26,216 of 42,892
- Rank in Japan
- #1,060 of 2,112
- Research works
- 234 ▼ 27% vs 2013–17
- Citations
- 8.7k 37.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 33% world 28%
What is Roche (Japan) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #10,999 of 14,347 | 10.6% | 122 |
Each strip is that field’s whole ranked pool, with the notch where Roche (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Roche (Japan)?
Ranked on the composite score, Mikio Arisawa and Mitsuru Tateishi lead among researchers whose main affiliation is Roche (Japan).
- 1 Mikio Arisawa Japan · #831,437 worldwide 56 citations · 23 works
- 2 Mitsuru Tateishi Japan · #1,275,462 worldwide 30 citations · 15 works
Which keywords describe research at Roche (Japan)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Oxidative Stress, Pharmacology, Chemotherapy, Neurological Disorders, Drug Discovery, Cell Signaling and Synaptic Plasticity.
- Receptors
- Genomic Stability
- Immune Modulation
- Neuropeptides
- Anxiety
- Apoptosis
- Medicinal Chemistry
- Arrestin
- Neuroprotection
- Crystal Structure
- Metabolism
- Anticancer Agents
- Cancer Therapy
- Synthesis
- GABAergic
- Neuronal Circuits
- Cell Signaling
- Drug Discovery
- Neurological Disorders
- Oxidative Stress
- Inflammation
- Chemotherapy
- Pharmacology
- Cancer
- Synaptic Plasticity
- Signal Transduction
- Neurotransmission
- Stress
- Molecular Mechanisms
- Tumor Microenvironment
- Antioxidant
- Fungal Pathogens
- Neurotoxicity
- G-Protein-Coupled Receptors
- Reactive Oxygen Species
- Antimicrobial Activity
- Metabolic Regulation
- Genetic Variants
- Toxicology
- Opioid
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation21▲ 3.8×36 topics
- Oxidative Stress17▲ 3.9×27 topics
- Chemotherapy12▲ 7.3×9 topics
- Neurological Disorders12▲ 7.4×7 topics
- Pharmacology12▲ 15×8 topics
- Drug Discovery11▲ 12×8 topics
- Cancer11▲ 3.4×18 topics
- Cell Signaling11▲ 14×5 topics
- Synaptic Plasticity10▲ 14×2 topics
- Neuronal Circuits10▲ 22×2 topics
- Signal Transduction10▲ 17×4 topics
- GABAergic10▲ 31×1 topic
- Neurotransmission10▲ 31×1 topic
- Synthesis10▲ 6.9×12 topics
- Stress8▲ 9.0×5 topics
- Cancer Therapy8▲ 5.2×11 topics
- Molecular Mechanisms8▲ 18×2 topics
- Anticancer Agents7▲ 13×6 topics
- Tumor Microenvironment7▲ 8.9×6 topics
- Metabolism7▲ 4.8×11 topics
- Antioxidant7▲ 4.5×13 topics
- Crystal Structure7▲ 12×2 topics
- Fungal Pathogens7▲ 17×5 topics
- Neuroprotection7▲ 7.7×7 topics
- Neurotoxicity7▲ 15×4 topics
- Arrestin6▲ 34×1 topic
- G-Protein-Coupled Receptors6▲ 34×1 topic
- Medicinal Chemistry6▲ 7.1×6 topics
- Reactive Oxygen Species6▲ 5.4×6 topics
- Apoptosis6▲ 6.7×7 topics
- Antimicrobial Activity6▲ 14×5 topics
- Anxiety6▲ 7.0×2 topics
- Metabolic Regulation6▲ 8.8×4 topics
- Neuropeptides6▲ 24×2 topics
- Genetic Variants6▲ 11×2 topics
- Immune Modulation6▲ 17×3 topics
- Toxicology6▲ 12×7 topics
- Genomic Stability5▲ 24×2 topics
- Opioid5▲ 36×1 topic
- Receptors5▲ 36×1 topic
Which research topics does Roche (Japan) publish most on?
By volume in 2022–2025: Cryptography and Data Security, Advanced Authentication Protocols Security, Smart Grid Security and Resilience and Influenza Virus Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cryptography and Data Security Artificial Intelligence 0 works
- 2 Advanced Authentication Protocols Security Computer Networks and Communications 0 works
- 3 Smart Grid Security and Resilience Control and Systems Engineering 0 works
- 4 Influenza Virus Research Studies Epidemiology 0 works
- 5 Biosensors and Analytical Detection Biomedical Engineering 0 works
- 6 SARS-CoV-2 detection and testing Infectious Diseases 0 works
- 7 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
- 8 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 0 works
- 9 Mycobacterium research and diagnosis Epidemiology 0 works
- 10 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Roche (Japan)'s research output changed?
Output in 2018–2022 was 27% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.